{"doc_id": "33596412", "type of study": "Therapy", "title": "", "abstract": "Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders, previously untreatable and high-risk upgrade patients (SOLVE-CRT) trial.\nThe WiSE system is a novel, leadless endocardial system that can provide cardiac resynchronization therapy in patients who cannot be treated with a conventional epicardial left ventricular lead.\nSafety and efficacy were being evaluated in the pivotal, randomized, double-blind SOLVE-CRT Trial (Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy.) The trial was initiated in 2018; however, patient enrollment was significantly impacted by the COVID-19 pandemic necessitating a change in design.\nThis article describes the revised trial and the scientific rationale for the specific changes in the protocol.\nCopyright \u00a9 2021 Elsevier Inc. All rights reserved.\n", "Evidence Map": {"Enrollment": [{"term": "cardiac resynchronization therapy", "negation": "affirmed", "UMLS": {}, "start": 71, "end": 104}, {"term": "nonresponders , previously untreatable and high-risk upgrade", "negation": "affirmed", "UMLS": {}, "start": 108, "end": 168}, {"term": "(", "negation": "affirmed", "UMLS": {}, "start": 178, "end": 179}, {"term": "Cardiac Resynchronization Therapy", "negation": "affirmed", "UMLS": {}, "start": 154, "end": 187}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders , previously untreatable and high-risk upgrade patients ( SOLVE-CRT ) trial .", "Evidence Elements": {"Participant": [{"term": "cardiac resynchronization therapy", "negation": "affirmed", "UMLS": {}, "start": 71, "end": 104}, {"term": "nonresponders , previously untreatable and high-risk upgrade", "negation": "affirmed", "UMLS": {}, "start": 108, "end": 168}, {"term": "(", "negation": "affirmed", "UMLS": {}, "start": 178, "end": 179}], "Intervention": [{"term": "stimulation of the left ventricular endocardium", "negation": "affirmed", "UMLS": {}, "start": 19, "end": 66}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "The WiSE system is a novel , leadless endocardial system that can provide cardiac resynchronization therapy in patients who cannot be treated with a conventional epicardial left ventricular lead .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Safety and efficacy were being evaluated in the pivotal , randomized , double-blind SOLVE-CRT Trial ( Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy . ) The trial was initiated in 2018 ; however , patient enrollment was significantly impacted by the COVID-19 pandemic necessitating a change in design .", "Evidence Elements": {"Participant": [{"term": "Cardiac Resynchronization Therapy", "negation": "affirmed", "UMLS": {}, "start": 154, "end": 187}], "Intervention": [{"term": "Stimulation of the Left Ventricular Endocardium", "negation": "affirmed", "UMLS": {}, "start": 102, "end": 149}], "Outcome": [{"term": "Safety", "negation": "affirmed", "UMLS": {}, "start": 0, "end": 6}, {"term": "efficacy", "negation": "affirmed", "UMLS": {}, "start": 11, "end": 19}], "Observation": [{"term": "impacted", "negation": "affirmed", "UMLS": {}, "start": 273, "end": 281}], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "This article describes the revised trial and the scientific rationale for the specific changes in the protocol .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Copyright \u00a9 2021 Elsevier Inc . All rights reserved .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}